A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis

Autor: Piscitelli, Stephen C., Pavel, Ana B., McHale, Kimberly, Jett, John E., Collins, Jon, Gillmor, Dawn, Tabolt, Glenn, Li, Randall, Song, Teresa, Zhang, Ning, Tallman, Anna M., Guttman-Yassky, Emma
Zdroj: In Journal of Investigative Dermatology July 2021 141(7):1847-1851
Databáze: ScienceDirect